» Authors » Lori Armstrong

Lori Armstrong

Explore the profile of Lori Armstrong including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 189
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Armstrong L
Biomed Instrum Technol . 2018 Mar; 52(2):140-143. PMID: 29558179
No abstract available.
2.
Lippold S, Carter J, Armstrong L, Hardison X
J Health Dispar Res Pract . 2017 Aug; 7(2). PMID: 28845366
Objective: To describe the decline of tuberculosis (TB) cases among U.S.-born non-Hispanic (NH) black and white Chicago residents. Methods: Data from the National TB Surveillance System was used to analyze...
3.
Marks S, Hirsch-Moverman Y, Seaworth B, Salcedo K, Graviss E, Armstrong L, et al.
Int J Tuberc Lung Dis . 2017 Mar; 21(4):477-478. PMID: 28284273
No abstract available.
4.
Bondurant P, Nielsen-Farrell J, Armstrong L
J Perinat Neonatal Nurs . 2015 Apr; 29(2):170-8. PMID: 25919607
Neonatal intensive care units (NICUs) are at high risk for medical errors due to the population, setting, and complexity of care. Furthermore, "near misses" often precede actual errors yet are...
5.
Marks S, Flood J, Seaworth B, Hirsch-Moverman Y, Armstrong L, Mase S, et al.
Emerg Infect Dis . 2014 Apr; 20(5):812-21. PMID: 24751166
To describe factors associated with multidrug-resistant (MDR), including extensively-drug-resistant (XDR), tuberculosis (TB) in the United States, we abstracted inpatient, laboratory, and public health clinic records of a sample of MDR...
6.
Shah N, Pratt R, Armstrong L, Robison V, Castro K, Cegielski J
JAMA . 2008 Nov; 300(18):2153-60. PMID: 19001626
Context: Worldwide emergence of extensively drug-resistant tuberculosis (XDR-TB) has raised global public health concern, given the limited therapy options and high mortality. Objectives: To describe the epidemiology of XDR-TB in...
7.
Myers M, Chang M, Jorgensen C, Whitworth W, Kassim S, Litch J, et al.
Genet Med . 2006 Jun; 8(6):361-70. PMID: 16778598
Purpose: To assess the impact of direct-to-consumer marketing of genetic testing for risk of breast and ovarian cancer by a biotechnology company on: 1) physicians' knowledge; 2) reasons given when...
8.
McDavid K, Schymura M, Armstrong L, Santilli L, Schmidt B, Byers T, et al.
Cancer Causes Control . 2005 Apr; 15(10):1057-66. PMID: 15801489
Background: Investigators from the Centers for Disease Control and Prevention (CDC), National Program of Cancer Registries (NPCR), are collaborating with public health professionals from seven states and the District of...